
501 - 1000 employees
🏥 Healthcare
💼 Consulting
📦 Logistics
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
Healthcare • Consulting • Logistics
BioCryst Pharmaceuticals, Inc. is a global biotechnology company focused on the discovery, development, and commercialization of novel oral small-molecule and protein therapeutics for rare diseases, notably hereditary angioedema (HAE). Founded in 1986, BioCryst uses structure-guided drug design, medicinal chemistry, and advanced technologies to develop first-in-class or best-in-class medicines, and works closely with patients, advocacy groups, and global partners to bring treatments to market.
Selected: 🆕 Date Added.
🕒 Yesterday
Sr. Clinical Data Manager overseeing global clinical trial data management for BioCryst. Coordinating CROs, vendors, data cleaning, database locks, and regulatory submission support.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 10%
🕒 3 days ago
Product Safety Associate supporting BioCryst’s postmarketing pharmacovigilance operations. Managing safety intake, adverse-event case support, reconciliations, and vendor oversight.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟢 Junior
🟡 Mid-level
✨ Associate
👻 Ghost score 10%
🕒 3 days ago
Senior Clinical Data Manager overseeing global clinical trial data management for BioCryst’s rare-disease therapeutics. Leading data cleaning, CRO coordination, database locking, and regulatory submission support.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 10%
🕒 3 days ago
Regional Business Director leading BioCryst’s rare-disease sales team and regional P&L. Driving business plans, customer relationships, compliance, and commercial performance across the Great Lakes.
🌽 Illinois, North Carolina, +2 more states – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 3 days ago
Contracts Manager negotiating clinical trial and commercial agreements for BioCryst, a rare-disease biopharmaceutical company. Managing contracting workflows, obligations, templates, and legal operations across a global organization.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
👻 Ghost score 10%
🕒 October 2
Executive Director leading biometrics for BioCryst’s rare-disease therapeutics development. Overseeing clinical-study statistics, programming, regulatory strategy, and CRO operations.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 October 1
Patient Support Manager guiding patients through reimbursement, onboarding, and adherence for BioCryst’s rare-disease therapies. Coordinating pharmacies, providers, vendors, and cross-functional teams.
🏖️ New Jersey, North Carolina, +1 more states – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
👻 Ghost score 20%
🗣️🇪🇸 Spanish Required
🕒 October 1
IT Business Partner guiding technology strategy, systems, and compliant data solutions for BioCryst’s pharmaceutical development programs. Leading platforms, projects, vendors, and clinical-development technology improvements.
🌲 North Carolina, Massachusetts – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 September 28
Regulatory affairs strategy leader advancing BioCryst’s rare-disease therapeutics. Managing global approvals, lifecycle submissions, FDA filings, and development strategies.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 10%
🕒 September 25
VP Biostatistics leading statistical strategy, clinical-trial analysis, and regulatory submissions for BioCryst’s rare-disease therapeutics. Managing biostatistics staff, CROs, and global agency interactions.
🍂 Massachusetts – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 10%
🕒 September 25
Executive Director leading statistical programming for BioCryst’s rare-disease therapeutics. Overseeing clinical-trial analyses, regulatory submissions, programmers, and CRO partnerships.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 September 21
Associate Director leading analytical development, release testing, and regulatory support for BioCryst’s biologics portfolio. Managing external CDMO and laboratory partners from development through commercialization.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 September 17
Rare Disease Specialist marketing BioCryst’s oral and injectable therapeutics to healthcare customers across the Los Angeles–Las Vegas territory. Building demand, managing key accounts, and exceeding sales goals.
🏄 California, North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
👻 Ghost score 10%
🕒 September 17
Clinical development leader advancing BioCryst’s rare-disease therapeutics through global trials. Leading multidisciplinary teams, study execution, clinical data quality, and regulatory submissions.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 10%
🕒 August 28
BioCryst VP leading global clinical development for rare-disease therapeutics. Directing clinical programs, teams, vendors, budgets, and patient-focused trial strategy.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 13%
🕒 August 25
Rare Disease Specialist marketing BioCryst’s oral and injectable rare-disease therapeutics across New York’s Hudson Valley. Driving compliant customer engagement, account growth, and territory sales performance.
🗽 New York – Remote
💵 $182k - $210k / year
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
👻 Ghost score 4%
🕒 August 25
Executive Director leading US payer access and pull-through strategies for BioCryst’s rare-disease therapeutics. Managing market access teams, accounts, launches, and reimbursement partnerships.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 14%
🕒 July 15
Director leading drug product development for BioCryst’s biologics portfolio. Overseeing formulation, process development, and collaboration with external partners.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 25%